These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36007557)

  • 1. Smart Oral pH-Responsive Dual Layer Nano-Hydrogel for Dissolution Enhancement and Targeted Delivery of Naringenin Using Protein-Polysaccharides Complexation Against Colorectal Cancer.
    Md S; Abdullah S; Awan ZA; Alhakamy NA
    J Pharm Sci; 2022 Nov; 111(11):3155-3164. PubMed ID: 36007557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
    Kumar SP; Birundha K; Kaveri K; Devi KT
    Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
    Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
    Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S; Talluri S; Rangaraj N; Sampathi S
    AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Systems of Naringenin with Solubilizers Expand Its Capability to Prevent Neurodegenerative Diseases.
    Stasiłowicz-Krzemień A; Gołębiewski M; Płazińska A; Płaziński W; Miklaszewski A; Żarowski M; Adamska-Jernaś Z; Cielecka-Piontek J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel self-nanomicellizing formulation based on Rebaudioside A: A potential nanoplatform for oral delivery of naringenin.
    Wang H; He Y; Hou Y; Geng Y; Wu X
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110926. PubMed ID: 32409076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
    Akhter MH; Kumar S; Nomani S
    Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles.
    Fuster MG; Carissimi G; Montalbán MG; Víllora G
    Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32290154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of a novel oral 5-Fluorouracil in-situ gelling nanosuspension to potentiate the anticancer activity against colorectal cancer cells.
    Abdullah S; El Hadad S; Aldahlawi A
    Int J Pharm; 2022 Feb; 613():121406. PubMed ID: 34968681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.
    Yen FL; Wu TH; Lin LT; Cham TM; Lin CC
    Pharm Res; 2009 Apr; 26(4):893-902. PubMed ID: 19034626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart pH-responsive Co-polymeric Hydrogels for Controlled Delivery of Capecitabine: Fabrication, Optimization and In Vivo Toxicology Screening.
    Rehman U; Sarfraz RM; Mahmood A; Hussain Z; Thu HE; Zafar N; Ashraf MU; Batool N
    Curr Drug Deliv; 2021; 18(9):1256-1271. PubMed ID: 33583374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic understanding of salt-induced drug encapsulation in nanosuspension via acid-base neutralization as a nanonization platform technology to enhance dissolution rate of pH-dependent poorly water-soluble drugs.
    Van Ngo H; Park C; Tran TTD; Nguyen VH; Lee BJ
    Eur J Pharm Biopharm; 2020 Sep; 154():8-17. PubMed ID: 32634569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of Naringenin-loaded nanoparticles for targeting of Vanin-1, iNOS, and MCP-1 signaling pathway in HFD-induced obesity.
    Salah A; Mohammed El-Laban N; Mafiz Alam S; Shahidul Islam M; Abdalla Hussein M; Roshdy T
    Int J Pharm; 2024 Apr; 654():123967. PubMed ID: 38438083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization:
    Ma Y; Yang J; Zhang Y; Zheng C; Liang Z; Lu P; Song F; Wang Y; Zhang J
    Drug Deliv; 2022 Dec; 29(1):111-127. PubMed ID: 34964414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates.
    Tran CTM; Tran PHL; Tran TTD
    Drug Dev Ind Pharm; 2019 Mar; 45(3):514-519. PubMed ID: 30575412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stoichiometrically Governed Curcumin Solid Dispersion and Its Cytotoxic Evaluation on Colorectal Adenocarcinoma Cells.
    Mohamed JMM; Alqahtani A; Ahmad F; Krishnaraju V; Kalpana K
    Drug Des Devel Ther; 2020; 14():4639-4658. PubMed ID: 33173275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, optimization, characterization and in vitro release of baicalein-solubilizing glycyrrhizic acid nano-micelles.
    You G; Feng T; Zhang G; Chen M; Liu F; Sun L; Wang M; Ren X
    Int J Pharm; 2021 May; 601():120546. PubMed ID: 33794322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Smart pH-responsive Nano-Carrier as a Drug Delivery System: A hybrid system comprised of mesoporous nanosilica MCM-41 (as a nano-container) & a pH-sensitive polymer (as smart reversible gatekeepers): Preparation, characterization and in vitro release studies of an anti-cancer drug.
    Abbaszad Rafi A; Mahkam M; Davaran S; Hamishehkar H
    Eur J Pharm Sci; 2016 Oct; 93():64-73. PubMed ID: 27497878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.